A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women
- 29 October 2001
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 38 (5) , 1302-1306
- https://doi.org/10.1016/s0735-1097(01)01554-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Inflammatory Markers of Coronary RiskNew England Journal of Medicine, 2000
- Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart DiseaseNew England Journal of Medicine, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged MenCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease CasesCirculation, 1997
- Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Influence of a Cigarette Smoke Extract on the Hormonal Regulation of Platelet-Activating Factor Acetylhydrolase in Rats1Biology of Reproduction, 1995
- Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseNature, 1995